| Date Filed | Type | Description |
| 10/03/2023 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Granted 150,437 options to buy
@ $1.55, valued at
$233.2k
|
|
| 10/02/2023 |
3
| Robinson James A. Jr. (Director) has filed a Form 3 on Eledon Pharmaceuticals, Inc. |
| 07/28/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/27/2023 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 20,000 options to buy
@ $8.9, valued at
$178k
|
|
| 07/27/2023 |
3
| Robinson James A. Jr. (Director) has filed a Form 3 on UroGen Pharma Ltd. |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Granted 23,453 shares
@ $0 |
|
| 03/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2020 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 12,480 shares
@ $0 |
|
| 07/11/2019 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 25,000 options to buy
@ $8.78, valued at
$219.5k
|
|
| 06/17/2019 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Granted 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
| 04/05/2019 |
4
| Robinson James A. Jr. (President & COO,Alkermes, Inc.) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 1,838 shares
@ $35.89, valued at
$66k
Exercised 6,250 options to buy
@ $0 |
|
| 03/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/25/2019 |
4
| Robinson James A. Jr. (President & COO,Alkermes, Inc.) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 40,400 options to buy
@ $0
Granted 157,000 options to buy
@ $32.57, valued at
$5.1M
|
|
| 01/30/2019 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $2.03, valued at
$25.4k
|
|
| 01/30/2019 |
3
| Robinson James A. Jr. (Director) has filed a Form 3 on Neos Therapeutics, Inc. |
| 07/03/2018 |
4
| Robinson James A. Jr. (President & COO,Alkermes, Inc.) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 140,000 options to buy
@ $44.16, valued at
$6.2M
Granted 25,000 options to buy
@ $0 |
|
| 03/14/2018 |
3
| Robinson James A. Jr. (President & COO,Alkermes, Inc.) has filed a Form 3 on Alkermes plc. |